Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis (Q47961515)

7 February 2018

title

Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis (English)

1 reference

7 February 2018

0 references

Inoue T

1 reference

7 February 2018

Ohnishi A

1 reference

7 February 2018

Matsuo A

1 reference

7 February 2018

Kawai B

1 reference

7 February 2018

Kunihiro N

1 reference

7 February 2018

Tada Y

1 reference

7 February 2018

Koizumi F

1 reference

7 February 2018

Chau T

1 reference

7 February 2018

Okada K

1 reference

7 February 2018

Yamamura Y

1 reference

7 February 2018

Tanaka T

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

7 February 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

7 February 2018

volume

1 reference

7 February 2018

issue

1 reference

7 February 2018

page(s)

561-570

1 reference

7 February 2018

Role of vasopressin in abnormal water excretion in cirrhotic patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

Antidiuretic hormone and renal function after water loading in patients with cirrhosis of the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

Vasopressin receptor antagonism in rhesus monkey and man: stereochemical requirements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

No requirement of cyclic conformation of antagonists in binding to vasopressin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

Survival prediction in portacaval shunts: A computerized statistical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

Renal and hormonal responses to repeated treatment with enalapril in non-azotemic cirrhosis with ascites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

Impaired renal water excretion in early hepatic cirrhosis. Lack of relationship between renal water excretion and plasma levels of arginine vasopressin, angiotensin II, and aldosterone after water loading

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

Disturbed relationship between urinary prostaglandin E2 excretion, plasma arginine vasopressin and renal water excretion after oral water loading in early hepatic cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

Effect of plasma membrane fluidity on serotonin transport by endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

Vasopressin-prostaglandin interactions in the regulation of epithelial cell permeability to water

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

An explanation for and experimental correction of the abnormal water diuresis in cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

Mechanisms of improvement of water and sodium excretion by immersion in decompensated cirrhotic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990107-2

10.1016/S0009-9236(98)90107-2

7 January 2021

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018